Comparison of outcomes from current ADAPT FAST, SWIFT, TREVO, NASA, and stent retriever meta-analysis
| ADAPT FAST (n=100) | SWIFT trial (n=89) | TREVO trial (n=88) | STAR study (n=202) | NASA registry (n=354) | Solitaire data* (n=355) | Trevo data* (n=221) | |
|---|---|---|---|---|---|---|---|
| TICI 2a/2b/3 (%) | N/A | 83† | 90 | N/A | 87.5 | 82 | 83 |
| Device TICI 2b/3 (%) | 78 | 75.9‡ | 68‡ | 79‡ 91§ | 72.5 | NR | NR |
| Final TICI 2b/3 (%) | 95 | 75.9‡ | 68‡ | 85 | 72.5 | 82 | 83 |
| mRS 0–2 (%) | 40 | 36 | 40 | 55 | 42 | 47 | 51 |
| Mortality (%) | 20 | 17 | 34 | 19 | 30.2 | 14 | 31 |
| Time to final revascularization (min) | 37 | NR | NR | NR | 50¶ | NR | NR |
| Device related complications (%) | 2 | 8.6 | 9 | 7.5 | NR | 6 | 5 |
| Symptomatic ICH (%) | 0 | 2 | 7 | 4 | 9.9 | 6 | 8 |
*Meta-analysis of real world published experience.
†Site reported rate of recanalization.
‡Core laboratory reported.
§Site investigator reported data.
¶Time to revascularize after guide catheter access.
ICH, intracerebral hemorrhage; mRS, modified Rankin Scale; N/A, not applicable; NR, not reported; TICI, Thrombolysis in Cerebral Infarction.